QQ客服 官方微博 反馈留言

	The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells
	Sun, Yehong[1,2]; Li, Tiyuan[2]; Ma, Kewei[3]; Tian, Zhongkai[2]; Zhu, Ying[2]; Chen, Fuqiang[2]; Hu, Gang[1]
	2009
卷号	27期号:[db:dc_citation_issue]页码:891
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3338526
专题	暨南大学
作者单位	1.[1]Nanjing Med Univ, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China 2.[2]Jinan Univ, Shenzhen Clin Med Res Ctr, Med Coll 2, Shenzhen Peoples Hosp, Shenzhen 518020, Guangdong, Peoples R China 3.[3]Jilin Univ, Hosp 1, Dept Hemotol & Oncol, Changchun 130021, Peoples R China
推荐引用方式 GB/T 7714	Sun, Yehong[1,2],Li, Tiyuan[2],Ma, Kewei[3],et al. The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells[J],2009,27([db:dc_citation_issue]):891.
APA	Sun, Yehong[1,2].,Li, Tiyuan[2].,Ma, Kewei[3].,Tian, Zhongkai[2].,Zhu, Ying[2].,...&Hu, Gang[1].(2009).The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells.,27([db:dc_citation_issue]),891.
MLA	Sun, Yehong[1,2],et al."The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells".27.[db:dc_citation_issue](2009):891.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。